National Resources:
FDA Drug Shortages & Discontinuations
Rpharmy Memorial Drug Shortage Information: (updated 8/1/2025)
Drug Products on Critical Shortage | |
Drug Name | Details |
capsaicin 0.025% topical ream | Supply is depleted. Est. release: none |
conjugated estrogen injectable | Supply is critical. Est. release none. |
dexamethasone oral solution | Supply is depleted. Ext release Aug 2025 |
dronabinol oral capsules | Supply is critical. Est. release: none |
erythromycin injectable | Supply is nearly depleted. Est. release Dec 2025 |
hydrocortisone 0.5% cream | Supply is nearly depleted. Est. release: None |
hydroxocobalamin 5g injectable | Available, however manufacturer is unable to guarantee sterility of 5 g Cyanokit (see letter). Should be administered using a 0.2 micron in-line filter to prevent potential microbial infection. |
lorazepam injectable | Supply is critical. Est. release: varied, unpredictable, and in small quantities |
meperidine injectable | Supply is critical. Est. release: Nov 2025 and Jan 2029 |
methylprednisolone 2 mg tablets | Supply is depleted. Estimated release: Jun 2026 |
penicillin G benzathine injectable | Supply is critical due to product recall. Est. release: none |
Drug Products on Shortage - Limited Availability | |
Drug Name | Details |
alteplase 100 mg vials | Supply is limited. Est release: none |
megestrol 40 mg tablets | Supply is limited. Some on allocation with other manufacturers est. release: Aug 2025. |
methadone oral solution | Supply is limited. Est. release Aug 2025 |
morphine oral solid formulations | Supply is critical on some, limited on others. Est. release: varied, unpredictable, and in small quantities |
sodium bicarbonate 4.2% injectable | Supply of 10ml syringes is depleted. 10ml vials remain available. Est. release: Jan 2026 |
sodium bicarbonate 8.4% injectable | Supply of 10ml syringes and vials are depleted. Est. release: Feb 2026 |
Relevant Products on National Shortage – No Practice Changes Needed | |
Drug Name | Details |
insulin glargine vials | Supply is adequate to meet needs. |
risperidone ODT (oral disintegrating tablet) | Supply is adequate to meed needs. |
Discontinued (no longer being manufactured) | |
Drug Name | Notes/Information |
lindane products | All presentations have been discontinued FDA Orange Book |
testosterone transdermal patches | All presentations have been discontinued FDA Orange Book |